TrialScope, in conjunction with EMD Serono, has launched a new clinical trials website. The site is designed to inform the public and healthcare professionals about clinical trials in general and provide details on EMD Serono clinical trials. EMD Serono Clinical...
BOTHELL, Wash., and TOKYO, Dec. 2, 2019 /PRNewswire/ — Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”), today announced a clinical collaboration agreement with Merck,...
SALT LAKE CITY, Dec. 3, 2019 /PRNewswire/ — Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced the dosing of the first participant enrolled in the REPAIR-PD study with its lead nanocatalytic therapy, CNM-Au8, for the treatment...
Biospace’s Mark Terry Clinical Trial Review Even with a shortened week due to the U.S. Thanksgiving holiday, there was plenty of clinical trial news and updates. Here’s a look. Genentech, a Roche company, presented positive results from the Phase III IMbrave150...
Enrollment Complete for Phase 2 Trial of AGO13 in Oral Mucositis Oragenics, Inc. (NYSE:OGEN) is currently conducting a Phase 2 clinical trial of its lead development compound AG013 in the prevention of severe oral mucositis (OM). AG013 is an oral mouth rinse composed...
Email
Text